Lilly CEO says Mass. gift limits may drive drug developers away

09/21/2008 | American City Business Journals

A Massachusetts law that allows the state government to limit how pharmaceutical firms market their products to doctors could hamper clinical research and scare life sciences investors away, said John Lechleiter, Eli Lilly and Co.'s president and CEO. Physicians need to be informed about innovations from drugmakers and deserve compensation "for their valuable time," Lechleiter said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA